Advisory Board

The HBA advisory board provides strategic direction on how the HBA can further the advancement of women’s careers in healthcare worldwide through HBA initiatives. The board is made up of an invited group of senior executives in the healthcare industry that represent a diverse membership and who are willing to support the HBA mission for a three-year term.

Beth Battaglino, director of advocacy and alliance

Shideh Sedgh Bina, founding partner
Insigniam

Paula Brown Stafford, biopharmaceutical services executive

Carolyn Buck Luce, executive in residence
Center for Talent Innovation
senior managing director,
Hewlett Consulting Partners

Jennifer Cook, head of pharma region, Europe
Roche

William Fitzsimmons, PharmD, executive vice president, regulatory affairs, clinical and research quality assurance
Astellas

Geno Germano, president
Intrexon Corporation

Brian Goff, executive vice president and president, Hematology
Baxalta, Inc.

Buket Grau, vice president, asset executive
Biogen

Adele Gulfo, executive vice president and chief strategy officer 
Mylan

Bridgette Heller, executive vice president, early life nutrition
Danone

Annalisa Jenkins, chief executive officer
Dimension Therapeutics

Sandip Kapadia, CFO
Intercept Pharmaceuticals, Inc.

Jacopo Leonardi, executive vice president, president of Immunology division
Baxalta, Inc.

Terri Pascarelli, chief executive officer
AIT Bioscience, LLC

Kristine Peterson, biopharmaceutical executive

Kim Ramko, Americas advisory life sciences sector lead
EY

David Ricks, senior vice president and president, Lilly bio-medicines
Eli Lilly and Company

Kevin Rigby, general manager
Rigby Consulting, LLC

Tracy Rossin, head of corporate affairs
MedImmune

Deborah Coogan Seltzer, director enhanced search, North America
Spencer Stuart

Christi Shaw, US country head, president of Novartis Corporation and Novartis Pharmaceuticals Corporation (NPC)
Novartis Pharmaceuticals Corporation

Stuart Sowder, PharmD, JD, vice president of external medical communications  
Pfizer

Denice Torres, chief strategy and business transformation officer
Johnson & Johnson Medical Devices

Susan Torroella, executive vice president 
Wellness Corporate Solutions, LLC

Tim Zuber, partner
KPMG

Jeanne Zucker, vice president, client development
athenahealth